261 related articles for article (PubMed ID: 15722070)
1. Bioavailability of the Yuzpe and levonorgestrel regimens of emergency contraception: vaginal vs. oral administration.
Kives S; Hahn PM; White E; Stanczyk FZ; Reid RL
Contraception; 2005 Mar; 71(3):197-201. PubMed ID: 15722070
[TBL] [Abstract][Full Text] [Related]
2. Comparison of vaginal and oral administration of emergency contraception.
Mor E; Saadat P; Kives S; White E; Reid RL; Paulson RJ; Stanczyk FZ
Fertil Steril; 2005 Jul; 84(1):40-5. PubMed ID: 16009155
[TBL] [Abstract][Full Text] [Related]
3. Assessment of two emergency contraceptive regimens in Iran: levonorgestrel versus the Yuzpe.
Farajkhoda T; Khoshbin A; Enjezab B; Bokaei M; Karimi Zarchi M
Niger J Clin Pract; 2009 Dec; 12(4):450-2. PubMed ID: 20329690
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and endometrial tissue levels of levonorgestrel after administration of a single 1.5-mg dose by the oral and vaginal route.
Devoto L; Fuentes A; Palomino A; Espinoza A; Kohen P; Ranta S; von Hertzen H
Fertil Steril; 2005 Jul; 84(1):46-51. PubMed ID: 16009156
[TBL] [Abstract][Full Text] [Related]
5. Effects of oral and vaginal administration of levonorgestrel emergency contraception on markers of endometrial receptivity.
Meng CX; Marions L; Byström B; Gemzell-Danielsson K
Hum Reprod; 2010 Apr; 25(4):874-83. PubMed ID: 20139427
[TBL] [Abstract][Full Text] [Related]
6. Levonorgestrel versus the "Yuzpe" regimen. New choices in emergency contraception.
Lee SM; Dunn S; Evans MF
Can Fam Physician; 1999 Mar; 45():629-31. PubMed ID: 10099801
[TBL] [Abstract][Full Text] [Related]
7. The combined contraceptive vaginal ring, NuvaRing, and tampon co-usage.
Verhoeven CH; Dieben TO
Contraception; 2004 Mar; 69(3):197-9. PubMed ID: 14969666
[TBL] [Abstract][Full Text] [Related]
8. Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trial.
Archer DF; Stanczyk FZ; Rubin A; Foegh M
Contraception; 2012 Jun; 85(6):595-601. PubMed ID: 22133660
[TBL] [Abstract][Full Text] [Related]
9. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Task Force on Postovulatory Methods of Fertility Regulation.
Lancet; 1998 Aug; 352(9126):428-33. PubMed ID: 9708750
[TBL] [Abstract][Full Text] [Related]
10. Treatment with liraglutide--a once-daily GLP-1 analog--does not reduce the bioavailability of ethinyl estradiol/levonorgestrel taken as an oral combination contraceptive drug.
Jacobsen LV; Vouis J; Hindsberger C; Zdravkovic M
J Clin Pharmacol; 2011 Dec; 51(12):1696-703. PubMed ID: 21228406
[TBL] [Abstract][Full Text] [Related]
11. Therapeutically equivalent pharmacokinetic profile across three application sites for AG200-15, a novel low-estrogen dose contraceptive patch.
Stanczyk FZ; Archer DF; Rubin A; Foegh M
Contraception; 2013 Jun; 87(6):744-9. PubMed ID: 23228503
[TBL] [Abstract][Full Text] [Related]
12. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
13. A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel.
Endrikat J; Blode H; Gerlinger C; Rosenbaum P; Kuhnz W
Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):79-90. PubMed ID: 12201326
[TBL] [Abstract][Full Text] [Related]
14. The emergency contraceptive drug, levonorgestrel: a review of post-coital oral and peri-coital vaginal administration for prevention of pregnancy.
Sarkar NN
J Obstet Gynaecol; 2011 Nov; 31(8):703-7. PubMed ID: 22085058
[TBL] [Abstract][Full Text] [Related]
15. Levonorgestrel as an emergency contraceptive drug.
Sarkar NN
Int J Clin Pract; 2003 Nov; 57(9):824-8. PubMed ID: 14686573
[TBL] [Abstract][Full Text] [Related]
16. Release of progestin-only emergency contraception.
Schwartz JL
Curr Womens Health Rep; 2001 Dec; 1(3):191-5. PubMed ID: 12112969
[TBL] [Abstract][Full Text] [Related]
17. Steady-state pharmacokinetics of an extended-regimen oral contraceptive with continuous estrogen.
DiLiberti CE; O'Leary CM; Hendy CH; Waters DH; Margolis MB
Contraception; 2011 Jan; 83(1):55-61. PubMed ID: 21134504
[TBL] [Abstract][Full Text] [Related]
18. A randomised study comparing a low dose of mifepristone and the Yuzpe regimen for emergency contraception.
Ashok PW; Stalder C; Wagaarachchi PT; Flett GM; Melvin L; Templeton A
BJOG; 2002 May; 109(5):553-60. PubMed ID: 12066946
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers.
Cawello W; Rosenkranz B; Schmid B; Wierich W
Epilepsia; 2013 Mar; 54(3):530-6. PubMed ID: 23360419
[TBL] [Abstract][Full Text] [Related]
20. Levonorgestrel is more effective, has fewer side-effects, than Yuzpe regimen.
Prog Hum Reprod Res; 1999; (51):3-5. PubMed ID: 12349416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
